EPHE 📈 iShares MSCI Philippines - Overview

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US46429B4086 • Miscellaneous Region

EPHE: Philippines, Stocks, Equities, Securities, Investments

The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is a free float-adjusted market capitalization-weighted index that is designed to measure the performance of the large-, mid- and small-capitalization segments of the equity market in the Philippines. The fund is non-diversified. ‣ Company URL: http://www.ishares.com ‣ Domicile: United States

Additional Sources for EPHE ETF

EPHE ETF Overview

Market Cap in USD 97m
Category Miscellaneous Region
TER 0.59%
IPO / Inception 2010-09-28

EPHE ETF Ratings

Growth 5y -25.5%
Fundamental -
Dividend 51.9%
Rel. Strength Industry -102
Analysts -
Fair Price Momentum 22.72 USD
Fair Price DCF -

EPHE Dividends

Dividend Yield 12m 1.46%
Yield on Cost 5y 1.15%
Annual Growth 5y 14.31%
Payout Consistency 86.2%

EPHE Growth Ratios

Growth Correlation 3m -93.2%
Growth Correlation 12m 16.6%
Growth Correlation 5y -24.8%
CAGR 5y -4.64%
CAGR/Mean DD 5y -0.27
Sharpe Ratio 12m -0.29
Alpha -23.22
Beta 0.74
Volatility 22.18%
Current Volume 11.4k
Average Volume 20d 60.7k
What is the price of EPHE stocks?
As of December 27, 2024, the stock is trading at USD 24.94 with a total of 11,400 shares traded.
Over the past week, the price has changed by +2.93%, over one month by -2.13%, over three months by -14.85% and over the past year by -0.54%.
Is iShares MSCI Philippines a good stock to buy?
Probably not. Based on ValueRay Analyses, iShares MSCI Philippines (NYSE ARCA:EPHE) is currently (December 2024) not a good stock to buy. It has a ValueRay Growth Rating of -25.48 and therefor a somwhat technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EPHE as of December 2024 is 22.72. This means that EPHE is currently overvalued and has a potential downside of -8.9%.
Is EPHE a buy, sell or hold?
iShares MSCI Philippines has no consensus analysts rating.
What are the forecast for EPHE stock price target?
According to ValueRays Forecast Model, EPHE iShares MSCI Philippines will be worth about 25.1 in December 2025. The stock is currently trading at 24.94. This means that the stock has a potential upside of +0.48%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 25.1 0.5%